SCHEMBL395069

SCHEMBL395069

CC(=O)OC1CC(=O)OC1=O

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.34
TSHR P16473 2/20 0.33
ALOX15 P16050 1/20 0.33
TAS2R46 P59540 2/20 0.33
OPRK1 P41145 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29539236 1.00 POLB (0.34) POLBTSHRALOX15TAS2R46OPRK1
SCHEMBL410612 1.00 POLB (0.34) POLBTSHRALOX15TAS2R46OPRK1
SCHEMBL395068 1.00 POLB (0.34) POLBTSHRALOX15TAS2R46OPRK1
SCHEMBL2680848 0.82 ALDH1A1 (0.35) POLB
SCHEMBL28969037 0.80
SCHEMBL28430230 0.80
SCHEMBL12296039 0.77 POLB (0.32) POLBTSHR
SCHEMBL16708351 0.77
SCHEMBL3915013 0.76
SCHEMBL7107930 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 220 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115819685-B Side chain end-capped polycarboxylate superplasticizer and preparation method thereof 科之杰新材料集团有限公司 2025-02-11 CN claimed
CN-117222615-A Process for the preparation of phenyl ketones 阿尔萨达股份公司 2023-12-12 CN claimed
CN-116122057-A High-strength cold-resistant textile for aerospace use and manufacturing method thereof 西京学院 2023-05-16 CN claimed
CN-115819685-A Side chain end-capped polycarboxylate superplasticizer and preparation method thereof 科之杰新材料集团有限公司 2023-03-21 CN claimed
CN-114057992-A Resin composition for carbon fiber molding 上纬新材料科技股份有限公司 2022-02-18 CN claimed
CN-110698531-B Novel compound for improving microcirculation disturbance and preparation method thereof 首都医科大学附属北京中医医院 2020-11-03 CN claimed
CN-110698531-A Novel compound for improving microcirculation disturbance and preparation method thereof 首都医科大学附属北京中医医院 2020-01-17 CN claimed
EP-2305402-B1 METHOD FOR PRODUCING SILVER-CONTAINING POWDER AND CONDUCTIVE PASTE USING THE SAME DAINIPPON INK & CHEMICALS (JP) 2017-11-29 EP claimed
US-20120276595-A1 COMPOSITIONS AND METHODS COMPRISING CELLULASE VARIANTS WITH REDUCED AFFINITY TO NON-CELLULOSIC MATERIALS DANISCO US INC. (US) 2012-11-01 US claimed
EP-2288698-A2 COMPOSITIONS AND METHODS COMPRISING CELLULASE VARIANTS WITH REDUCED AFFINITY TO NON-CELLULOSIC MATERIALS Danisco US Inc. (US) 2011-03-02 EP claimed
US-20100041104-A1 Compositions and Methods Comprising Cellulase Variants with Reduced Affinity to Non-Cellulosic Materials DANISCO US INC. (US) 2010-02-18 US claimed
WO-2009149202-A2 COMPOSITIONS AND METHODS COMPRISING CELLULASE VARIANTS WITH REDUCED AFFINITY TO NON-CELLULOSIC MATERIALS DANISCO US INC., GENENCOR DIVISION (US) 2009-12-10 WO claimed
EP-1543074-B1 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP CO LTD (KR) 2008-02-27 EP claimed
US-7046904-B2 UV-curable resin composition for cladding optical fiber SSCP CO., LTD. (KR) 2006-05-16 US claimed
US-20060067638-A1 Uv-curable resin composition for cladding optical fiber LUVANTIX CO., LTD. (KR) 2006-03-30 US claimed
EP-1543074-A4 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP CO LTD (KR) 2006-01-04 EP claimed
EP-1543074-A1 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP Co., Ltd. (KR) 2005-06-22 EP claimed
WO-2004024814-A1 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP CO., LTD. (KR) 2004-03-25 WO claimed
US-5958119-A Hot melt ink compositions XEROX CORPORATION (US) 1999-09-28 US claimed
EP-4730479-A2 FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME Kyoto University (JP) 2026-04-22 EP disclosed
US-20250246685-A1 FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME KYOTO UNIVERSITY (JP) 2025-07-31 US disclosed
WO-2025120994-A1 SECONDARY BATTERY NON-AQUEOUS ELECTROLYTE AND SECONDARY BATTERY PROVIDED WITH SAME ステラケミファ株式会社 2025-06-12 WO disclosed
WO-2025095088-A1 NON-AQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY PROVIDED WITH SAID SOLUTION ステラケミファ株式会社 2025-05-08 WO disclosed
CN-115819685-B Side chain end-capped polycarboxylate superplasticizer and preparation method thereof 科之杰新材料集团有限公司 2025-02-11 CN disclosed
US-12191448-B2 Nonaqueous electrolyte solution for secondary battery, and secondary battery provided with said solution STELLA CHEMIFA CORPORATION (JP) 2025-01-07 US disclosed
EP-4428982-A1 FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME Kyoto University (JP) 2024-09-11 EP disclosed
WO-2024150597-A1 THERMOSETTING RESIN COMPOSITION, CURED FILM, SUBSTRATE, AND ELECTRONIC COMPONENT JNC株式会社 2024-07-18 WO disclosed
CN-118056309-A Flame-retardant nonaqueous electrolyte and secondary battery using same 国立大学法人京都大学 2024-05-17 CN disclosed
US-20240152047-A1 HIGH REFRACTIVE INDEX MATERIALS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2024-05-09 US disclosed
CN-117866195-A High refractive index material 罗门哈斯电子材料有限责任公司 2024-04-12 CN disclosed
EP-4313986-A1 PROCESSES FOR MAKING BICYCLIC KETONE COMPOUNDS Genentech, Inc. (US) 2024-02-07 EP disclosed
US-20240034739-A1 PROCESSES FOR MAKING BICYCLIC KETONE COMPOUNDS GENENTECH, INC. (US) 2024-02-01 US disclosed
CN-114478347-B Refining method of wiener kalant intermediate 上海旭东海普药业有限公司 2023-12-22 CN disclosed
CN-117098762-A Process for preparing bicyclic ketone compounds 基因泰克公司 2023-11-21 CN disclosed
CN-114031535-B Improved synthesis method of wiener kalant hydrochloride 上海旭东海普药业有限公司 2023-08-25 CN disclosed
CN-116122057-A High-strength cold-resistant textile for aerospace use and manufacturing method thereof 西京学院 2023-05-16 CN disclosed
US-20230145826-A1 FLUORESCENT LABELING AGENT AND FLUORESCENT DYE TOYO INK SC HOLDINGS CO., LTD. (JP) 2023-05-11 US disclosed
WO-2023079988-A1 FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME 国立大学法人京都大学 2023-05-11 WO disclosed
US-20230145826-A1 FLUORESCENT LABELING AGENT AND FLUORESCENT DYE TOYO INK SC HOLDINGS CO., LTD. (JP) 2023-05-11 US disclosed
CN-115819685-A Side chain end-capped polycarboxylate superplasticizer and preparation method thereof 科之杰新材料集团有限公司 2023-03-21 CN disclosed
WO-2022270517-A1 OIL-RESISTANT AGENT ダイキン工業株式会社 2022-12-29 WO disclosed
WO-2022212809-A1 PROCESSES FOR MAKING BICYCLIC KETONE COMPOUNDS GENENTECH, INC. (US) 2022-10-06 WO disclosed
CN-114478347-A Refining method of Vernakalant intermediate 上海旭东海普药业有限公司 2022-05-13 CN disclosed
CN-108475822-B Nonaqueous electrolyte solution for secondary battery and secondary battery provided with same 斯泰拉化工公司 2022-03-11 CN disclosed
CN-114057992-A Resin composition for carbon fiber molding 上纬新材料科技股份有限公司 2022-02-18 CN disclosed
CN-114031535-A Improved synthesis method of vernakalant hydrochloride 上海旭东海普药业有限公司 2022-02-11 CN disclosed
WO-2022002077-A1 ARYL AROMATIC HETEROCYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海海和药物研究开发股份有限公司 2022-01-06 WO disclosed
CN-113861161-A Aryl aromatic heterocyclic derivative and preparation method and application thereof 上海海和药物研究开发股份有限公司 2021-12-31 CN disclosed
CN-107431245-B Nonaqueous electrolyte solution for secondary battery and secondary battery provided with same 斯泰拉化工公司 2021-08-10 CN disclosed
US-20210202991-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY PROVIDED WITH SAID SOLUTION STELLA CHEMIFA CORPORATION (JP) 2021-07-01 US disclosed
US-11020386-B2 Methods and compositions for preventing opioid abuse ALBANY MOLECULAR RESEARCH, INC. (US) 2021-06-01 US disclosed
US-11005125-B2 Nonaqueous electrolyte solution for secondary batteries and secondary battery provided with same STELLA CHEMIFA CORPORATION (JP) 2021-05-11 US disclosed
US-20210046428-A1 FUNCTIONALISED MIXED MATRIX MEMBRANES AND METHOD OF PRODUCTION HURRAH SARL (LU) 2021-02-18 US disclosed
EP-3765176-A1 FUNCTIONALISED MIXED MATRIX MEMBRANES AND METHOD OF PRODUCTION HurraH S.à r.l. (LU) 2021-01-20 EP disclosed
CN-110698531-B Novel compound for improving microcirculation disturbance and preparation method thereof 首都医科大学附属北京中医医院 2020-11-03 CN disclosed
US-10696852-B2 Silver paste, and conductive molded article obtained using same DIC CORPORATION (JP) 2020-06-30 US disclosed
US-10695342-B2 Methods and compositions for preventing opioid abuse ALBANY MOLECULAR RESEARCH, INC. (US) 2020-06-30 US disclosed
US-20200179428-A1 CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2020-06-11 US disclosed
EP-3396768-B1 NON-AQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY PROVIDED THEREWITH STELLA CHEMIFA CORP (JP) 2020-04-22 EP disclosed
CN-110698531-A Novel compound for improving microcirculation disturbance and preparation method thereof 首都医科大学附属北京中医医院 2020-01-17 CN disclosed
WO-2019175366-A1 FUNCTIONALISED MIXED MATRIX MEMBRANES AND METHOD OF PRODUCTION HURRAH SARL (LU) 2019-09-19 WO disclosed
EP-3539645-A1 FUNCTIONALISED MIXED MATRIX MEMBRANES AND METHOD OF PRODUCTION HurraH S.à r.l. (LU) 2019-09-18 EP disclosed
EP-3471738-A1 CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES Merck Sharp & Dohme Corp. (US) 2019-04-24 EP disclosed
US-10226456-B2 Methods and compositions for preventing opioid abuse 3ST RESEARCH LLC (US) 2019-03-12 US disclosed
EP-3396768-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY PROVIDED WITH SAID SOLUTION Stella Chemifa Corporation (JP) 2018-10-31 EP disclosed
US-20180301756-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME STELLA CHEMIFA CORP (JP) 2018-10-18 US disclosed
EP-3309890-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME Stella Chemifa Corporation (JP) 2018-04-18 EP disclosed
US-9901543-B2 Thermogelling composition Klomed Pharma (BE) 2018-02-27 US disclosed
US-20180034102-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME STELLA CHEMIFA CORP (JP) 2018-02-01 US disclosed
US-20180026303-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME STELLA CHEMIFA CORP (JP) 2018-01-25 US disclosed
US-20180019498-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME STELLA CHEMIFA CORPORATION (JP) 2018-01-18 US disclosed
WO-2017223020-A1 CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2017-12-28 WO disclosed
EP-3258531-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME Stella Chemifa Corporation (JP) 2017-12-20 EP disclosed
US-20170342279-A1 SILVER PASTE, AND CONDUCTIVE MOLDED ARTICLE OBTAINED USING SAME DIC CORPORATION (JP) 2017-11-30 US disclosed
EP-2305402-B1 METHOD FOR PRODUCING SILVER-CONTAINING POWDER AND CONDUCTIVE PASTE USING THE SAME DAINIPPON INK & CHEMICALS (JP) 2017-11-29 EP disclosed
EP-3232445-A1 SILVER PASTE, AND CONDUCTIVE MOLDED ARTICLE OBTAINED USING SAME DIC Corporation (JP) 2017-10-18 EP disclosed
US-20170197009-A1 Sterilized Thermogelling Composition KIOMED PHARMA (BE) 2017-07-13 US disclosed
US-9695407-B2 Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials DANISCO US INC (US) 2017-07-04 US disclosed
US-20170157116-A1 METHODS AND COMPOSITIONS FOR PREVENTING OPIOID ABUSE CURIA BUFFALO R&D, LLC 2017-06-08 US disclosed
US-20170151232-A1 METHODS AND COMPOSITIONS FOR PREVENTING OPIOID ABUSE CURIA BUFFALO R&D, LLC 2017-06-01 US disclosed
US-20170135952-A1 Thermogelling Composition KIOMED PHARMA (BE) 2017-05-18 US disclosed
US-9586899-B2 Synthetic process for aminocyclohexyl ether compounds CARDIOME PHARMA CORP. (CA) 2017-03-07 US disclosed
EP-2288698-B1 COMPOSITIONS AND METHODS COMPRISING CELLULASE VARIANTS WITH REDUCED AFFINITY TO NON-CELLULOSIC MATERIALS DANISCO US INC (US) 2016-12-21 EP disclosed
US-20160326182-A1 METHODS AND COMPOSITIONS FOR PREVENTING OPIOID ABUSE CURIA BUFFALO R&D, LLC 2016-11-10 US disclosed
EP-1923418-B1 STAR POLYMER AND PROCESS FOR PRODUCTION THEREOF NIPPON SODA CO (JP) 2016-11-09 EP disclosed
EP-2171055-B1 METHODS FOR IMPROVING MULTIPLE PROTEIN PROPERTIES DANISCO US INC (US) 2016-03-16 EP disclosed
US-20160032267-A1 METHODS FOR IMPROVING MULTIPLE PROTEIN PROPERTIES DANISCO US INC. (US) 2016-02-04 US disclosed
WO-2015200591-A1 POLYURETHANES, ARTICLES COMPRISING THE SAME AND METHODS OF MANUFACTURE THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-12-30 WO disclosed
US-20150336887-A1 SYNTHETIC PROCESS FOR AMINOCYCLOHEXYL ETHER COMPOUNDS CORREVIO CANADA CORP. (CA) 2015-11-26 US disclosed
US-20150329842-A1 COMPOSITIONS AND METHODS COMPRISING CELLULASE VARIANTS WITH REDUCED AFFINITY TO NON-CELLULOSIC MATERIALS DANISCO US INC. (US) 2015-11-19 US disclosed
US-9133425-B2 Methods for improving multiple protein properties DANISCO US INC. (US) 2015-09-15 US disclosed
US-9115081-B2 Synthetic process for aminocyclohexyl ether compounds CARDIOME PHARMA CORP. (CA) 2015-08-25 US disclosed
US-8999692-B2 Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials DANISCO US INC. (US) 2015-04-07 US disclosed
EP-1780224-B1 MULTIBRANCHED POLYMERS AND PROCESS FOR PRODUCTION THEREOF NIPPON SODA CO (JP) 2015-02-18 EP disclosed
US-8618311-B2 Synthetic processes for the preparation of aminocyclohexyl ether compounds CARDIOME PHARMA CORP. (CA) 2013-12-31 US disclosed
EP-2636734-A2 Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials Danisco US Inc. (US) 2013-09-11 EP disclosed
EP-2628795-A1 Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials Danisco US Inc. (US) 2013-08-21 EP disclosed
EP-2628796-A1 Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials Danisco US Inc. (US) 2013-08-21 EP disclosed
EP-2306994-B1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC (US) 2013-08-14 EP disclosed
EP-2626422-A1 Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials Danisco US Inc. (US) 2013-08-14 EP disclosed
EP-1915340-B1 SYNTHETIC PROCESSES FOR THE PREPARATION OF AMINOCYCLOHEXYL ETHER COMPOUNDS CARDIOME PHARMA CORP (CA) 2013-08-07 EP disclosed
EP-1931220-B1 FLAVOUR MODULATING SUBSTANCES GIVAUDAN NEDERLAND SERVICES BV (NL) 2013-05-29 EP disclosed
US-8436103-B2 Star polymer and method of producing the same NIPPON SODA CO., LTD. (JP) 2013-05-07 US disclosed
US-20130102791-A1 SYNTHETIC PROCESS FOR AMINOCYCLOHEXYL ETHER COMPOUNDS CARDIOME PHARMA CORP. (CA) 2013-04-25 US disclosed
US-20130090483-A1 SYNTHETIC PROCESSES FOR THE PREPARATION OF AMINOCYCLOHEXYL ETHER COMPOUNDS CARDIOME PHARMA CORP. (CA) 2013-04-11 US disclosed
US-20130041000-A1 NOVEL AZOLE COMPOUND AJINOMOTO CO., INC. (JP) 2013-02-14 US disclosed
US-8344162-B2 Synthetic processes for the preparation of aminocyclohexyl ether compounds CARDIOME PHARMA CORP. (CA) 2013-01-01 US disclosed
US-20120276595-A1 COMPOSITIONS AND METHODS COMPRISING CELLULASE VARIANTS WITH REDUCED AFFINITY TO NON-CELLULOSIC MATERIALS DANISCO US INC. (US) 2012-11-01 US disclosed
EP-2341510-B1 Blockcopolymer solid electrolyte, ion-conductive membrane and process for producing the blockcopolymer NIPPON SODA CO (JP) 2012-10-31 EP disclosed
US-20120271057-A9 SYNTHETIC PROCESSES FOR THE PREPARATION OF AMINOCYCLOHEXYL ETHER COMPOUNDS CARDIOME PHARMA CORP. (CA) 2012-10-25 US disclosed
US-8236542-B2 Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials DANISCO US INC. (US) 2012-08-07 US disclosed
US-20120065408-A1 SYNTHETIC PROCESSES FOR THE PREPARATION OF AMINOCYCLOHEXYL ETHER COMPOUNDS CARDIOME PHARMA CORP. (CA) 2012-03-15 US disclosed
US-8101223-B2 Flavour modulating substances GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2012-01-24 US disclosed
US-8080673-B2 Synthetic processes for the preparation of aminocyclohexyl ether compounds CARDIOME PHARMA CORP. (CA) 2011-12-20 US disclosed
US-7999107-B2 Psychological disorders; cognition activators; Alzheimer's disease; headaches; nervous system antiinflammatory agents; antiepileptic agents; Parkinson's disease; Huntington's disease; schizophrenia; eating disorders MERCK SHARP & DOHME CORP. (US) 2011-08-16 US disclosed
US-20110180764-A1 SILVER-CONTAINING POWDER, METHOD FOR PRODUCING THE SAME, CONDUCTIVE PASTE USING THE SAME, AND PLASTIC SUBSTRATE DIC CORPORATION (JP) 2011-07-28 US disclosed
EP-2341510-A1 Blockcopolymer solid electrolyte, ion-conductive membrane and process for producing the blockcopolymer Nippon Soda Co., Ltd. (JP) 2011-07-06 EP disclosed
US-20110152388-A1 Multibranched polymer and method for producing the same NIPPON SODA CO., LTD. (JP) 2011-06-23 US disclosed
US-20110152388-A1 Multibranched polymer and method for producing the same NIPPON SODA CO., LTD. (JP) 2011-06-23 US disclosed
EP-2306994-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF Amgen, Inc (US) 2011-04-13 EP disclosed
EP-2305402-A1 SILVER-CONTAINING POWDER, METHOD FOR PRODUCING THE SAME, CONDUCTIVE PASTE USING THE SAME, AND PLASTIC SUBSTRATE DIC Corporation (JP) 2011-04-06 EP disclosed
US-7919570-B2 narrowly dispersed; controlled molecular weight; ionic conductivity, shape stability; battery adhesive or binder; 1,1,2,2-tetrakis(4-hydroxyphenyl)ethane or pentaerythritol reacted with bromoisobutyroyl bromide for core; living radical polymerization of acrylate or a styrene at halogen atoms as the arms NIPPON SODA CO., LTD. (JP) 2011-04-05 US disclosed
US-7919570-B2 narrowly dispersed; controlled molecular weight; ionic conductivity, shape stability; battery adhesive or binder; 1,1,2,2-tetrakis(4-hydroxyphenyl)ethane or pentaerythritol reacted with bromoisobutyroyl bromide for core; living radical polymerization of acrylate or a styrene at halogen atoms as the arms NIPPON SODA CO., LTD. (JP) 2011-04-05 US disclosed
EP-2109615-B1 SUBSTITUTED PYRANO [2, 3 - B]PYRIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS MERCK SHARP & DOHME (US) 2011-03-09 EP disclosed
EP-2288698-A2 COMPOSITIONS AND METHODS COMPRISING CELLULASE VARIANTS WITH REDUCED AFFINITY TO NON-CELLULOSIC MATERIALS Danisco US Inc. (US) 2011-03-02 EP disclosed
US-7842685-B2 S1P1 receptor agonists and use thereof AMGEN INC. (US) 2010-11-30 US disclosed
US-20100216682-A1 Methods for Improving Multiple Protein Properties DANISCO US INC. 2010-08-26 US disclosed
US-20100152464-A1 SYNTHETIC PROCESS FOR AMINOCYCLOHEXYL ETHER COMPOUNDS CARDIOME PHARMA CORP. (CA) 2010-06-17 US disclosed
EP-2171055-A2 METHODS FOR IMPROVING MULTIPLE PROTEIN PROPERTIES Danisco US Inc. (US) 2010-04-07 EP disclosed
US-7678860-B2 e.g.block copolymer of methoxypolyethylene glycol mono (meth)acrylate with monomers selected from unsaturated ether, alcohol, ester, nitrile, carboxy, anhydride etc.; excellent in thermal properties, physical properties and ion conductivity NIPPON SODA CO., LTD. (JP) 2010-03-16 US disclosed
US-7678860-B2 e.g.block copolymer of methoxypolyethylene glycol mono (meth)acrylate with monomers selected from unsaturated ether, alcohol, ester, nitrile, carboxy, anhydride etc.; excellent in thermal properties, physical properties and ion conductivity NIPPON SODA CO., LTD. (JP) 2010-03-16 US disclosed
US-20100041104-A1 Compositions and Methods Comprising Cellulase Variants with Reduced Affinity to Non-Cellulosic Materials DANISCO US INC. (US) 2010-02-18 US disclosed
US-20100029611-A1 S1P1 receptor agonists and use thereof AMGEN INC. (US) 2010-02-04 US disclosed
WO-2009154775-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC. (US) 2009-12-23 WO disclosed
WO-2009149202-A2 COMPOSITIONS AND METHODS COMPRISING CELLULASE VARIANTS WITH REDUCED AFFINITY TO NON-CELLULOSIC MATERIALS DANISCO US INC., GENENCOR DIVISION (US) 2009-12-10 WO disclosed
EP-2109615-A1 SUBSTITUTED PYRANO [2, 3 - B]PYRIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS Merck & Co., Inc. (US) 2009-10-21 EP disclosed
US-20090170911-A1 NOVEL AZOLE COMPOUND AJINOMOTO CO. INC (JP) 2009-07-02 US disclosed
US-20090124690-A1 Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins CERNOFINA, LLC 2009-05-14 US disclosed
US-20090118436-A1 Star Polymer and Method of Producing the Same NIPPON SODA CO., LTD. (JP) 2009-05-07 US disclosed
US-20090118436-A1 Star Polymer and Method of Producing the Same NIPPON SODA CO., LTD. (JP) 2009-05-07 US disclosed
US-7517996-B2 Azole compound AJINOMOTO CO., INC. (JP) 2009-04-14 US disclosed
WO-2008153925-A9 METHODS FOR IMPROVING MULTIPLE PROTEIN PROPERTIES DANISCO US INC GENENCOR DIV (US) 2009-03-12 WO disclosed
US-20090035356-A1 MODIFIED BIODEGRADABLE POLYMERS, PREPARATION AND USE THEREOF FOR MAKING BIOMATERIALS AND DRESSINGS BUI-KHAC TRUNG 2009-02-05 US disclosed
US-7479571-B2 Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins CERNOFINA, LLC (US) 2009-01-20 US disclosed
WO-2008153925-A2 METHODS FOR IMPROVING MULTIPLE PROTEIN PROPERTIES DANISCO US, INC., GENENCOR DIVISION (US) 2008-12-18 WO disclosed
US-20080268122-A1 Flavour Modulating Substances QUEST INTERNATIONAL SERVICES B.V. 2008-10-30 US disclosed
US-20080214685-A1 Multibrached Polymer and Method for Producing the Same NIPPON SODA CO., LTD. (JP) 2008-09-04 US disclosed
US-20080214685-A1 Multibrached Polymer and Method for Producing the Same NIPPON SODA CO., LTD. (JP) 2008-09-04 US disclosed
US-20080207666-A1 Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators MERCK SHARP & DOHME CORP. 2008-08-28 US disclosed
WO-2008094476-A1 SUBSTITUTED PYRANO [2, 3 - B] PYRIDINE DERIVATIVES AS CANNABINOID -1 RECEPTOR MODULATORS MERCK & CO., INC. (US) 2008-08-07 WO disclosed
EP-1931220-A1 FLAVOUR MODULATING SUBSTANCES Quest International Services B.V. (NL) 2008-06-18 EP disclosed
EP-1923418-A1 STAR POLYMER AND PROCESS FOR PRODUCTION THEREOF NIPPON SODA CO., LTD. (JP) 2008-05-21 EP disclosed
EP-1543074-B1 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP CO LTD (KR) 2008-02-27 EP disclosed
EP-1558252-B1 SUBSTITUTED FURO [2,3-B]PYRIDINE DERIVATIVES MERCK & CO INC (US) 2007-10-10 EP disclosed
EP-1828099-A1 SYNTHETIC PROCESS FOR AMINOCYCLOHEXYL ETHER COMPOUNDS Cardimone Pharma Corporation (CA) 2007-09-05 EP disclosed
EP-1780224-A1 MULTIBRANCHED POLYMERS AND PROCESS FOR PRODUCTION THEREOF NIPPON SODA CO., LTD. (JP) 2007-05-02 EP disclosed
WO-2007040399-A1 FLAVOUR MODULATING SUBSTANCES QUEST INTERNATIONAL SERVICES B.V. (NL) 2007-04-12 WO disclosed
US-20070040145-A1 e.g.block copolymer of methoxypolyethylene glycol mono (meth)acrylate with monomers selected from unsaturated ether, alcohol, ester, nitrile, carboxy, anhydride etc.; excellent in thermal properties, physical properties and ion conductivity NIPPON SODA CO., LTD. (JP) 2007-02-22 US disclosed
US-20070040145-A1 e.g.block copolymer of methoxypolyethylene glycol mono (meth)acrylate with monomers selected from unsaturated ether, alcohol, ester, nitrile, carboxy, anhydride etc.; excellent in thermal properties, physical properties and ion conductivity NIPPON SODA CO., LTD. (JP) 2007-02-22 US disclosed
US-20060194850-A1 Novel azole compound AJINOMOTO CO. INC (JP) 2006-08-31 US disclosed
WO-2006088525-A1 SYNTHETIC PROCESS FOR AMINOCYCLOHEXYL ETHER COMPOUNDS CARDIOME PHARMA CORP. (CA) 2006-08-24 WO disclosed
US-7091216-B2 Substituted furo[2,3-b]pyridine derivatives MERCK & CO., INC. (US) 2006-08-15 US disclosed
US-7046904-B2 UV-curable resin composition for cladding optical fiber SSCP CO., LTD. (KR) 2006-05-16 US disclosed
US-20060067638-A1 Uv-curable resin composition for cladding optical fiber LUVANTIX CO., LTD. (KR) 2006-03-30 US disclosed
EP-1543074-A4 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP CO LTD (KR) 2006-01-04 EP disclosed
US-20050272763-A1 Substituted furo[2,3-b]pyridine derivatives MERCK SHARP & DOHME CORP. 2005-12-08 US disclosed
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
EP-1543074-A1 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP Co., Ltd. (KR) 2005-06-22 EP disclosed
EP-0924238-B1 Neutralization method for polyorganosiloxanes DOW CORNING (US) 2005-02-16 EP disclosed
US-6780822-B2 THICKENERS; VISCOELECTRICITY FLUIDS FOR WELLS VENTURE CHEMICALS, INC. 2004-08-24 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
EP-0903383-B1 Hot melt ink compositions XEROX CORP (US) 2004-07-07 EP disclosed
US-6730289-B2 HAIR STYLING MIXTURE COMPRISING AN ACYLATED CARBAMATE GROUP MODIFIED POLYURETHANE AND ACCEPTABLE CARRIER OR DILUENT; NO DEPOSITS ON HAIR, WATER SOLUBLE UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2004-05-04 US disclosed
WO-2004024814-A1 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP CO., LTD. (KR) 2004-03-25 WO disclosed
EP-1398312-A1 Beta-substituted-gamma-butyrolactones and a process for preparation thereof Uh, Hong-Sun (KR) 2004-03-17 EP disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-6656885-B2 Containing a polar additive comprising water soluble compounds containing one or more hydroxyl groups and/or one or more amino groups; drilling a well utilizing such fluids. VENTURE INNOVATIONS, INC. 2003-12-02 US disclosed
WO-2003071085-A2 ANHYDRIDE-MODIFIED CHITOSAN, METHOD OF PREPARATION THEREOF, AND FLUIDS CONTAINING SAME VENTURE INNOVATIONS, INC. (US) 2003-08-28 WO disclosed
US-20030153467-A1 Anhydride-modified chitosan, method of preparation thereof, and fluids containing same VENTURE CHEMICALS, INC. 2003-08-14 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-20020176837-A1 Cosmetic composition UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2002-11-28 US disclosed
WO-2002064698-A1 VISCOSIFIED AQUEOUS CHITOSAN-CONTAINING WELL DRILLING AND SERVICING FLUIDS VENTURE INNOVATIONS, INC. (US) 2002-08-22 WO disclosed
WO-2002058645-A1 POLYURETHANES, COSMETIC COMPOSITIONS CONTAINING THEM AND METHOD OF PREPARATION UNILEVER PLC (GB) 2002-08-01 WO disclosed
US-20020098987-A1 Anhydride-modified chitosan, method of preparation thereof, and fluids containing same VENTURE CHEMICALS INC. 2002-07-25 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
US-6376151-B1 HYDROXYPOLYAMIDES ASAHI KASEI KABUSHIKI KAISHA (JP) 2002-04-23 US disclosed
US-6358889-B2 SUCCINIC ANHYDRIDE-TYPE MODIFIER; ALDEHYDE AND/OR PYRUVIC ACID VENTURE INNOVATIONS, INC. 2002-03-19 US disclosed
US-6323240-B1 HALOGENATED DERIVATIVES AS ENZYME INHIBITORS PHARMACIA & UPJOHN S.P.A. (IT) 2001-11-27 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed
JP-2001226368-A METHOD FOR PRODUCING O-ACETYLMALIC ANHYDRIDE MITSUI CHEMICALS INC 2001-08-21 JP disclosed
US-20010009889-A1 Viscosified aqueous chitosan-containing well drilling and servicing fluids VENTURE CHEMICALS, INC. 2001-07-26 US disclosed
US-6258975-B1 HYPOTENSIVE AGENTS AJINOMOTO CO., INC. (JP) 2001-07-10 US disclosed
US-6242600-B1 ANTIISCHEMIC AGENTS, ANTICOAGULANTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-06-05 US disclosed
EP-1096316-A1 POSITIVE RESIST COMPOSITION Asahi Kasei Kabushiki Kaisha (JP) 2001-05-02 EP disclosed
US-6087526-A Process for producing optically active 2-hydroxy-4-arylbutyric acid or its ester AJINOMOTO CO., INC. (JP) 2000-07-11 US disclosed
EP-0759424-B1 Process for producing optically active 2-hydroxy-4-arylbutyric acid or its ester, and intermediate therefor AJINOMOTO KK (JP) 2000-06-14 EP disclosed
US-6027555-A Hot melt ink compositions XEROX CORPORATION (US) 2000-02-22 US disclosed
US-6017385-A Ink compositions XEROX CORPORATION (US) 2000-01-25 US disclosed
US-5958119-A Hot melt ink compositions XEROX CORPORATION (US) 1999-09-28 US disclosed
US-5959139-A Process for producing optically active 2-hydroxy-4-arylbutyric acid or its ester AJINOMOTO CO., INC. (JP) 1999-09-28 US disclosed
US-5931995-A Ink compositions XEROX CORPORATION (US) 1999-08-03 US disclosed
EP-0924238-A1 Neutralization method for polyorganosiloxanes DOW CORNING CORPORATION (US) 1999-06-23 EP disclosed
EP-0903383-A1 Hot melt ink compositions Xerox Corporation (US) 1999-03-24 EP disclosed
US-5847180-A Neutralization method for polyorganosiloxanes DOW CORNING CORPORATION (US) 1998-12-08 US disclosed
EP-0858443-A1 4-PHENYL-4-OXO-BUTANOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.p.A. (IT) 1998-08-19 EP disclosed
WO-1997017317-A1 4-PHENYL-4-OXO-BUTANOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.P.A. (IT) 1997-05-15 WO disclosed
EP-0759424-A1 Process for producing optically active 2-hydroxy-4-arylbutyric acid or its ester, and intermediate therefor Ajinomoto Co., Inc. (JP) 1997-02-26 EP disclosed
US-5359128-A Malic acid derivatives and compositions for the treatment of psoriasis BLANK IZHAK (IL) 1994-10-25 US disclosed
EP-0252744-B1 3-Beta-(3,4-disubstituted succinimido)azetidinones LILLY CO ELI (US) 1993-12-15 EP disclosed
WO-1992012952-A1 MALIC ACID DERIVATIVES AND COMPOSITIONS FOR THE TREATMENT OF PSORIASIS DEXTER CHEMICAL CORPORATION (US) 1992-08-06 WO disclosed
US-4734498-A 3β-succinimidoazetidinones as chiral intermediates ELI LILLY AND COMPANY (US) 1988-03-29 US disclosed
EP-0252744-A2 3-Beta-(3,4-disubstituted succinimido)azetidinones ELI LILLY AND COMPANY (US) 1988-01-13 EP disclosed
EP-0055028-B1 WATER-SOLUBLE POLYSACCHARIDES AND DIAGNOSTIC RADIO-LABELLED DERIVATES THEREOF MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1986-02-19 EP disclosed
US-4465839-A CYCLIZATION OF CARBODIIMIDE, ACID ANHYDRIDE, AND AROMATIC ALCOHOL BAYER AKTIENGESELLSCHAFT (DE) 1984-08-14 US disclosed
US-4460782-A FUNGICIDES CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) 1984-07-17 US disclosed
US-4385046-A FOR BLOOD CLOTS IN THE VASCULAR SYSTEM MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1983-05-24 US disclosed
EP-0055028-A1 Water-soluble polysaccharides and diagnostic radio-labelled derivates thereof MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1982-06-30 EP disclosed
US-4031025-A Chitosan derivative, sequestering agents for heavy metals SOCIETE ANONYME DITE: L'OREAL (FR) 1977-06-21 US disclosed
US-4018797-A Intermediates for prostaglandins THE DOW CHEMICAL COMPANY (US) 1977-04-19 US disclosed
US-3953608-A Cosmetic compositions for the skin containing a chitosan derivative L'OREAL (FR) 1976-04-27 US disclosed
US-3953608-A Cosmetic compositions for the skin containing a chitosan derivative L'OREAL (FR) 1976-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (27 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124690-A1 Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins SELP, SELE, SELPLG POLB 4370/4885TSHR 1794/4885ALOX15 2422/4885
US-10226456-B2 Methods and compositions for preventing opioid abuse OPRM1, OPRK1, OPRD1 POLB 1797/4885TSHR 4761/4885ALOX15 879/4885
US-20090035356-A1 MODIFIED BIODEGRADABLE POLYMERS, PREPARATION AND USE THEREOF FOR MAKING BIOMATERIALS AND DRESSINGS FIBP, CFD, COL14A1 POLB 3750/4885TSHR 4831/4885ALOX15 389/4885
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 POLB 3567/4885TSHR 1971/4885ALOX15 225/4885
US-20120065408-A1 SYNTHETIC PROCESSES FOR THE PREPARATION OF AMINOCYCLOHEXYL ETHER COMPOUNDS CYP2D6, CYP3A43, CYP2F1 POLB 3069/4885TSHR 699/4885ALOX15 4292/4885
US-20090170911-A1 NOVEL AZOLE COMPOUND LPAR1, LPAR2, LPAR3 POLB 4575/4885TSHR 539/4885ALOX15 113/4885
US-10695342-B2 Methods and compositions for preventing opioid abuse OPRM1, OPRK1, OPRD1 POLB 1797/4885TSHR 4761/4885ALOX15 879/4885
US-11005125-B2 Nonaqueous electrolyte solution for secondary batteries and secondary battery provided with same CA12, CA2, CA1 POLB 554/4885TSHR 3144/4885ALOX15 2638/4885
US-11020386-B2 Methods and compositions for preventing opioid abuse OPRM1, OPRK1, OPRD1 POLB 1797/4885TSHR 4761/4885ALOX15 879/4885
US-20130102791-A1 SYNTHETIC PROCESS FOR AMINOCYCLOHEXYL ETHER COMPOUNDS DDC, PAICS, CYP4F2 POLB 1537/4885TSHR 1066/4885ALOX15 3560/4885
US-20200179428-A1 CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES PNP, TYMP, ENTPD5 POLB 174/4885TSHR 3213/4885ALOX15 3729/4885
US-20100029611-A1 S1P1 receptor agonists and use thereof S1PR1, S1PR5, S1PR2 POLB 4253/4885TSHR 349/4885ALOX15 445/4885
US-20050272763-A1 Substituted furo[2,3-b]pyridine derivatives CNR1, CNR2, FAAH POLB 1522/4885TSHR 973/4885ALOX15 310/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 POLB 3489/4885TSHR 1888/4885ALOX15 214/4885
US-20150336887-A1 SYNTHETIC PROCESS FOR AMINOCYCLOHEXYL ETHER COMPOUNDS DDC, PAICS, CYP4F2 POLB 1537/4885TSHR 1066/4885ALOX15 3560/4885
US-20160326182-A1 METHODS AND COMPOSITIONS FOR PREVENTING OPIOID ABUSE OPRM1, OPRK1, OPRD1 POLB 1797/4885TSHR 4761/4885ALOX15 879/4885
US-20240034739-A1 PROCESSES FOR MAKING BICYCLIC KETONE COMPOUNDS HSD17B7, BCKDK, CYP11B1 POLB 1767/4885TSHR 2458/4885ALOX15 2540/4885
US-20180019498-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES AND SECONDARY BATTERY PROVIDED WITH SAME CA12, CA2, CA1 POLB 554/4885TSHR 3144/4885ALOX15 2638/4885
US-20080207666-A1 Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators CNR1, CNR2, FAAH POLB 1646/4885TSHR 877/4885ALOX15 444/4885
US-20130090483-A1 SYNTHETIC PROCESSES FOR THE PREPARATION OF AMINOCYCLOHEXYL ETHER COMPOUNDS CYP2D6, CYP3A43, CYP2F1 POLB 3069/4885TSHR 699/4885ALOX15 4292/4885
US-20020176837-A1 Cosmetic composition POLR1C, ALKBH5, HAT1 POLB 259/4885TSHR 2486/4885ALOX15 2331/4885
US-20170157116-A1 METHODS AND COMPOSITIONS FOR PREVENTING OPIOID ABUSE OPRM1, OPRK1, OPRD1 POLB 1797/4885TSHR 4761/4885ALOX15 879/4885
US-20130041000-A1 NOVEL AZOLE COMPOUND LPAR1, LPAR2, LPAR3 POLB 4575/4885TSHR 539/4885ALOX15 113/4885
US-20100152464-A1 SYNTHETIC PROCESS FOR AMINOCYCLOHEXYL ETHER COMPOUNDS DDC, PAICS, CYP4F2 POLB 1537/4885TSHR 1066/4885ALOX15 3560/4885
US-20060194850-A1 Novel azole compound LPAR1, LPAR2, LPAR3 POLB 4575/4885TSHR 539/4885ALOX15 113/4885
US-20120271057-A9 SYNTHETIC PROCESSES FOR THE PREPARATION OF AMINOCYCLOHEXYL ETHER COMPOUNDS CYP2D6, CYP3A43, CYP2F1 POLB 3069/4885TSHR 699/4885ALOX15 4292/4885
US-20170151232-A1 METHODS AND COMPOSITIONS FOR PREVENTING OPIOID ABUSE OPRM1, OPRK1, OPRD1 POLB 1797/4885TSHR 4761/4885ALOX15 879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.